UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma

Leukemia & lymphoma, 2023-01, Vol.64 (2), p.407-414

2023

Volltextzugriff (PDF)

Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases

The Annals of pharmacotherapy, 2021-06, Vol.55 (6), p.697-704

2021

Volltextzugriff (PDF)

COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma

Annals of hematology, 2023-09, Vol.102 (9), p.2635-2637

2023

Volltextzugriff (PDF)

Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis

Journal of oncology pharmacy practice, 2024-10, Vol.30 (6), p.1089-1095

2024

Volltextzugriff (PDF)

Clinical controversies in the treatment of cancer-associated venous thromboembolism

Journal of Oncology Pharmacy Practice, 2021-06, Vol.27 (4), p.939-953

2021

Volltextzugriff (PDF)

Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma

Expert review of hematology, 2023-12, Vol.16 (12), p.915-918

2023

Volltextzugriff (PDF)

PET-guided, BEACOPP escalated therapy in advanced Hodgkin lymphoma

The lancet oncology, 2019-04, Vol.20 (4), p.e188

2019

Volltextzugriff (PDF)

Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma

Leukemia & lymphoma, 2020-02, Vol.61 (3), p.691-698

2020

Volltextzugriff (PDF)

Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?

Journal of clinical oncology, 2019-11, Vol.37 (31), p.2952-2952

2019

Volltextzugriff (PDF)

Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management

Supportive care in cancer, 2021-11, Vol.29 (11), p.6505-6510

2021

Volltextzugriff (PDF)

Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma

Journal of oncology pharmacy practice, 2020-07, Vol.26 (5), p.1248-1253

2020

Volltextzugriff (PDF)

Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective

Journal of Oncology Pharmacy Practice, 2022-04, Vol.28 (3), p.646-663

2022

Volltextzugriff (PDF)

Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma

Critical reviews in oncology/hematology, 2020-04, Vol.148, p.102897, Article 102897

2020

Volltextzugriff (PDF)

Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphoma

Leukemia & lymphoma, 2021-11, Vol.62 (13), p.3138-3146

2021

Volltextzugriff (PDF)

Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting

JCO oncology practice, 2021-09, Vol.17 (9), p.OP2000639-e1310

2021

Volltextzugriff (PDF)

Genomic and Biochemical Analysis of the Diaminopimelate and Lysine Biosynthesis Pathway in Verrucomicrobium spinosum: Identification and Partial Characterization of L,L-Diaminopimelate Aminotransferase and UDP-N-Acetylmuramoylalanyl-D-glutamyl-2,6-meso-Diaminopimelate Ligase

Frontiers in microbiology, 2012-01, Vol.3, p.183-183

2012

Volltextzugriff (PDF)

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia

Leukemia research, 2018-07, Vol.70, p.91-96

2018

Volltextzugriff (PDF)

Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas

Leukemia & lymphoma, 2020-04, Vol.61 (5), p.1126-1132

2020

Volltextzugriff (PDF)

Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Clinical lymphoma, myeloma and leukemia, 2021-05, Vol.21 (5), p.295-308

2021

Volltextzugriff (PDF)

Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)

JCO clinical cancer informatics, 2019-05 (3), p.1-6

2019

Volltextzugriff (PDF)

Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment

Leukemia research, 2017-12, Vol.63, p.56-61

2017

Volltextzugriff (PDF)

Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG

Annals of hematology, 2018-04, Vol.97 (4), p.573-584

2018

Volltextzugriff (PDF)

PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma

The lancet oncology, 2019-04, Vol.20 (4), p.e188-e188

2019

Volltextzugriff (PDF)

Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction

Journal of Onco-Nephrology, 2023-06, Vol.7 (2), p.49-56

2023

Volltextzugriff (PDF)

Multisite results from a practice-based self-assessment for oral anticancer agent (OAA) management

JCO oncology practice, 2023-11, Vol.19 (11_suppl), p.434-434

2023

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Oncology
(18)
Hematology
(11)
Humans
(8)
Pharmacology & Pharmacy
(5)
Retrospective Studies
(5)
Patients
(4)
Adult
(3)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Lymphoma
(3)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(3)
Medicine
(3)
Medicine & Public Health
(3)
Multiple Myeloma
(3)
Adolescent
(2)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(2)
Cancer
(2)
Dosage
(2)
Female
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma

Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases

COVID-19 infection outcomes in patients receiving CD20 targeting T-cell engaging bispecific antibodies for B-cell non-Hodgkin lymphoma

Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis

Clinical controversies in the treatment of cancer-associated venous thromboembolism

Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma

PET-guided, BEACOPP escalated therapy in advanced Hodgkin lymphoma

Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma

Dosing Vincristine in Dose-Adjusted EPOCH-R: To Cap or Not to Cap?

Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management

Successful rechallenge of rituximab following severe rituximab-induced acute thrombocytopenia in a patient with splenic marginal zone lymphoma

Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective

Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma

Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphoma

Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting

Genomic and Biochemical Analysis of the Diaminopimelate and Lysine Biosynthesis Pathway in Verrucomicrobium spinosum: Identification and Partial Characterization of L,L-Diaminopimelate Aminotransferase and UDP-N-Acetylmuramoylalanyl-D-glutamyl-2,6-meso-Diaminopimelate Ligase

The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia

Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas

Evaluating the Role of Novel Oncology Agents: Oncology Stewardship in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM)

Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment

Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG

PET-guided, BEACOPPescalated therapy in advanced Hodgkin lymphoma

Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction

Multisite results from a practice-based self-assessment for oral anticancer agent (OAA) management

Suchergebnisse filtern